| (210) | Number of the EPO application | 20169861 |
| (220) | Filing date of the EPO application | 2016.03.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 49/2023, 2023.12.06 |
| (110) | EPO patent number | 3744326 |
| (11) | Number of the document | MD 3744326 T2 |
| (21) | Number of the application | e 2021 0632 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | GOPAL Srihari, US;
RAVENSTIJN Paulien Gerarda Maria, BE;
RUSSU Alberto, BE;
SAMTANI Mahesh Narain, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | Dosing regimen for missed doses for long-acting injectable paliperidone esters |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/519 (2006.01.01); A61K 9/10 (2006.01.01); A61P 25/18 (2006.01.01); A61P 25/24 (2006.01.01); A61K 9/00 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2021.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.05.31 |
| (30) | Priority | 201562144054 P, 2015.04.07, US; 201562162596 P, 2015.05.15, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |